SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020513
Filing Date
2018-08-08
Accepted
2018-08-08 16:25:37
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20180630.htm 10-Q 1955124
2 EX-10.1 aimt-ex101_11.htm EX-10.1 84587
3 EX-31.1 aimt-ex311_8.htm EX-31.1 19447
4 EX-31.2 aimt-ex312_6.htm EX-31.2 19450
5 EX-32.1 aimt-ex321_7.htm EX-32.1 16884
6 GRAPHIC gd2i3nx4g454000002.jpg GRAPHIC 1902
7 GRAPHIC gaki2cvnxpya000001.jpg GRAPHIC 25238
8 GRAPHIC gd2i3nx4g454000001.jpg GRAPHIC 2274
  Complete submission text file 0001564590-18-020513.txt   5998173

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aimt-20180630.xml EX-101.INS 1324763
10 XBRL TAXONOMY EXTENSION SCHEMA aimt-20180630.xsd EX-101.SCH 32680
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20180630_cal.xml EX-101.CAL 30668
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20180630_def.xml EX-101.DEF 94462
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20180630_lab.xml EX-101.LAB 267805
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20180630_pre.xml EX-101.PRE 202996
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 181001730
SIC: 2834 Pharmaceutical Preparations